(UroToday.com) As part of a plenary presentation at the European Association of Urology (EAU) Virtual Annual Meeting assessing “modern prostate cancer imaging in daily practice”, Alastair Lamb Ph.D, FRCS(Urol), examined the question of what to do in men at risk of prostate cancer for whom you have decided not to biopsy or who have had an initial negative biopsy. He began by highlighting the two clinical scenarios: a man in whom the magnetic resonance imaging (MRI) was negative and a man in whom the biopsy was negative – both of whom are considering the question of their risk of cancer.